Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ovarian Neoplasms
  Free Subscription

Articles published in
J Natl Cancer Inst
    February 2024
  1. CAO A, Esserman DA, Cartmel B, Irwin ML, et al
    Association between diet quality and ovarian cancer risk and survival.
    J Natl Cancer Inst. 2024 Feb 23:djae040. doi: 10.1093.
    >> Share

    July 2023
  2. PHUNG MT, Lee AW, McLean K, Anton-Culver H, et al
    A framework for assessing interactions for risk stratification models: the example of ovarian cancer.
    J Natl Cancer Inst. 2023 Jul 12:djad137. doi: 10.1093.
    >> Share

    June 2023
  3. HURWITZ LM, Dogbe N, Hughes Barry K, Koutros S, et al
    Obesity and prostate cancer screening, incidence, and mortality in the PLCO Cancer Screening Trial.
    J Natl Cancer Inst. 2023 Jun 29:djad113. doi: 10.1093.
    >> Share

  4. LI S, Nguyen-Dumont T, Southey MC, Hopper JL, et al
    RE: Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer.
    J Natl Cancer Inst. 2023;115:757-759.
    >> Share

    May 2023
  5. SHI J, Kraft P, Rosner BA, Benavente Y, et al
    Risk prediction models for endometrial cancer: development and validation in an international consortium.
    J Natl Cancer Inst. 2023;115:552-559.
    >> Share

    April 2023
  6. GUPTA S, Hanna PE, Ouyang T, Yamada KS, et al
    Kidney Function in Patients with Ovarian Cancer Treated with Poly (ADP-ribose) polymerase (PARP) Inhibitors.
    J Natl Cancer Inst. 2023 Apr 19:djad070. doi: 10.1093.
    >> Share

    February 2023
  7. FOURNIER A, Cairat M, Severi G, Gunter MJ, et al
    Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
    J Natl Cancer Inst. 2023 Feb 21:djad035. doi: 10.1093.
    >> Share

  8. EVANS DG, Woodward ER
    RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer.
    J Natl Cancer Inst. 2023;115:224-225.
    >> Share

  9. MAJIDI A, Na R, Jordan SJ, DeFazio A, et al
    Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.
    J Natl Cancer Inst. 2023 Feb 6:djac239. doi: 10.1093.
    >> Share

    January 2023
  10. FU Z, Brooks MM, Irvin S, Jordan S, et al
    Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
    J Natl Cancer Inst. 2023 Jan 23:djad011. doi: 10.1093.
    >> Share

    November 2022
  11. SAFDAR NS, Stasenko M, Selenica P, Martin AS, et al
    Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.
    J Natl Cancer Inst. 2022;114:1545-1548.
    >> Share

    October 2022
  12. DEVRIES AA, Dennis J, Tyrer JP, Peng PC, et al
    Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
    J Natl Cancer Inst. 2022 Oct 10. pii: 6751998. doi: 10.1093.
    >> Share

    June 2022

  13. Correction to: Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Jun 17. pii: 6609827. doi: 10.1093.
    >> Share

    April 2022
  14. LEHRER S, Rheinstein PH
    RE: Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Apr 23. pii: 6572816. doi: 10.1093.
    >> Share

  15. SCHRIJVER LH, Mooij TM, Pijpe A, Sonke GS, et al
    Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
    J Natl Cancer Inst. 2022;114:540-552.
    >> Share

    March 2022
  16. TUESLEY KM, Webb PM, Protani MM, Spilsbury K, et al
    Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.
    J Natl Cancer Inst. 2022 Mar 9. pii: 6545294. doi: 10.1093.
    >> Share

    December 2021
  17. TAKAHASHI K
    Untangling the Relationship between Clonal Hematopoiesis and Ovarian Cancer Therapies.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486529. doi: 10.1093.
    >> Share

  18. WEBER-LASSALLE K, Ernst C, Reuss A, Mollenhoff K, et al
    Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients with Ovarian Cancer.
    J Natl Cancer Inst. 2021 Dec 28. pii: 6486427. doi: 10.1093.
    >> Share

    September 2021
  19. DE SOUZA C, Madden J, Koestler DC, Minn D, et al
    Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
    J Natl Cancer Inst. 2021;113:1246-1257.
    >> Share

    August 2021
  20. KURIAN AW, Abrahamse P, Bondarenko I, Hamilton AS, et al
    Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
    J Natl Cancer Inst. 2021 Aug 9. pii: 6346986. doi: 10.1093.
    >> Share

    July 2021
  21. CALLENS C, Vaur D, Soubeyran I, Rouleau E, et al
    Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
    J Natl Cancer Inst. 2021;113:917-923.
    >> Share

    March 2021
  22. WENZEL L, Osann K, McKinney C, Cella D, et al
    Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
    J Natl Cancer Inst. 2021 Mar 17. pii: 6174697. doi: 10.1093.
    >> Share

    November 2020
  23. PERES LC, Bethea TN, Camacho TF, Bandera EV, et al
    Racial differences in population attributable risk for epithelial ovarian cancer in the OCWAA Consortium.
    J Natl Cancer Inst. 2020 Nov 30. pii: 6012358. doi: 10.1093.
    >> Share

  24. SPAAN M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, et al
    Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology.
    J Natl Cancer Inst. 2020 Nov 17. pii: 5981708. doi: 10.1093.
    >> Share

    February 2020
  25. YANG X, Song H, Leslie G, Engel C, et al
    Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D.
    J Natl Cancer Inst. 2020 Feb 28. pii: 5764125. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016